Podcasts about focus on neurology and psychiatry

Host: Barry A. Singer, MD Patients living with MS can experience hidden or invisible symptoms that may not be apparent to others but can affect how they feel and function. In this podcast, Dr. Barry Singer, the Director at the Multiple Sclerosis Center for Innovations in Care, and Rosario, a patient who has been living with MS for 10 years, discuss their clinical and personal experiences with MS, and the impact that MS can have on a patient's QoL. In the 2-year AFFIRM pivotal trial: Relapsing MS patients received 300 mg TYSABRI every 28 days (n=627) or placebo (n=315). Patients with PPMS, SPMS, and PRMS were excluded.2,3 83% of patients taking TYSABRI had no sustained disability progression for 12 weeks vs 71% with placebo (primary endpoint: 17% vs 29%; p

Host: Barry A. Singer, MD Patients living with MS can experience hidden or invisible symptoms that may not be apparent to others but can affect how they feel and function. In this podcast, Dr. Barry Singer, the Director at the Multiple Sclerosis Center for Innovations in Care, and Rosario, a patient who has been living with MS for 10 years, discuss their clinical and personal experiences with MS, and the impact that MS can have on a patient's QoL. In the 2-year AFFIRM pivotal trial: Relapsing MS patients received 300 mg TYSABRI every 28 days (n=627) or placebo (n=315). Patients with PPMS, SPMS, and PRMS were excluded.2,3 83% of patients taking TYSABRI had no sustained disability progression for 12 weeks vs 71% with placebo (primary endpoint: 17% vs 29%; p

Host: Jacqueline Nicholas, MD, MPH Ever had a multiple sclerosis (MS) patient who needed to start a DMT? Listen to Dr. Jacqueline Nicholas, System Chief of Neuroimmunology and Director of MS Research at Ohio Health, and Kim, a patient who has been living with MS for seven years, share their experiences with the treatment decision process, including benefit-risk considerations, treatment goals, and patient preferences. They talk about the process for starting and continuing treatment with TYSABRI® (natalizumab) and how Biogen Support Services can help. Please see Important Safety Information, including Boxed Warning for PML, below.

Host: Jacqueline Nicholas, MD, MPH Ever had a multiple sclerosis (MS) patient who needed to start a DMT? Listen to Dr. Jacqueline Nicholas, System Chief of Neuroimmunology and Director of MS Research at Ohio Health, and Kim, a patient who has been living with MS for seven years, share their experiences with the treatment decision process, including benefit-risk considerations, treatment goals, and patient preferences. They talk about the process for starting and continuing treatment with TYSABRI® (natalizumab) and how Biogen Support Services can help. Please see Important Safety Information, including Boxed Warning for PML, below.

Guest: Caroline Hastings, MD Guest: Raymond Y. Wang, MD Niemann-Pick disease type C (NPC) is an ultra-rare, inherited, neurodegenerative disease with life-threatening complications. Due to its highly variable onset of neurological symptoms throughout one's lifespan, recognizing and establishing diagnosis for NPC can be challenging for any clinician. That's why Drs. Caroline Hastings and Raymond Y. Wang join Dr. Jennifer Caudle to help address those challenges with a detailed look at this genetic condition, the factors underlying its variable onset and course, and strategies to improve recognition, cross-specialty communications, and time to diagnosis. Copyright ©2021 Orphazyme A/S. All rights reserved.NP-USA-1492-v1ORPHAZYME is a trademark or registered trademark of Orphazyme A/S.

Host: Jennifer Caudle, DO Guest: Kathleen Blake, MD, MPH Guest: Peggy Chen, MD Behavioral health integration has proven to be an effective solution to improving access to treatment for many mental health conditions… So why is it not more prevalent in the medical community? Joining Dr. Jennifer Caudle to dive into the findings and implications of the joint AMA-RAND Corporation study recently published in the Annals of Internal Medicine are Dr. Kathleen Blake with the AMA and Dr. Peggy Chen from the RAND Corporation. And, click here to listen to a conversation regarding Behavioral Health Integration and its effect on clinical practice.

Host: Jennifer Caudle, DO Guest: Kathleen Blake, MD, MPH Guest: Peggy Chen, MD Behavioral health integration has proven to be an effective solution to improving access to treatment for many mental health conditions… So why is it not more prevalent in the medical community? Joining Dr. Jennifer Caudle to dive into the findings and implications of the joint AMA-RAND Corporation study recently published in the Annals of Internal Medicine are Dr. Kathleen Blake with the AMA and Dr. Peggy Chen from the RAND Corporation. And, click here to listen to a conversation regarding Behavioral Health Integration and its effect on clinical practice.

Host: Mario R. Nacinovich, Jr., MSc Guest: Paul Orchard, MD Although it only affects about one in 18,000 people, the impacts of adrenoleukodystrophy cannot be underestimated. That's why Dr. Paul Orchard joins Mario Nacinovich to talk about this rare—and fatal—genetic disease, why it's often underdiagnosed and confused with other conditions, and how we can treat it once we've reached an accurate diagnosis.

Host: Brian P. McDonough, MD, FAAFP Guest: Kisma Orbovich Improvement is something we're all constantly chasing, whether it's in the form of a promotion, a bigger house, or maybe even an ideal weight. So why do we often fail miserably at these attempts to make our lives better? To get to the bottom of this dilemma, Dr. Brian McDonough is joined by Kisma Orbovich, the CEO of Illumination Academy, to reveal the secret to true success and how gratitude may just be the lifehack we've been searching for.

Host: Brian P. McDonough, MD, FAAFP Guest: Teresa Gil, PhD Since about 21 million mothers in America experienced sexual abuse in their childhood, there's a good chance that some of these women are our patients. So as their physicians, how can we provide them with the best possible care as they continue to cope with the lifelong effects of sexual abuse? That's what Dr. Brian McDonough explores with Dr. Teresa Gil, author of Women Who Were Sexually Abused as Children: Mothering, Resilience, and Protecting the Next Generation.

Host: Patricia K. Coyle, MD Guest: Clyde E. Markowitz, MD Please note: This activity is no longer available for continuing education credit. Multiple sclerosis (MS) is one of the leading causes of disability worldwide. As the treatment armamentarium continues to grow, patient involvement in the development of an effective treatment strategy is becoming increasingly important. In this Clinical ExchangesSM activity, leading MS specialists discuss issues of diagnosing MS, initiating treatment, and switching therapies, all in the context of practical shared decision-making techniques demonstrated by their own patients.

Host: Andrew Wilner, MD, FACP, FAAN As a follow-up to the Microgravity: A New Risk Factor for Idiopathic Intracranial Hypertension essay he wrote back in 2012, Dr. Andrew Wilner investigates whether there have been any updates on the 27 astronauts who had significant microgravity exposure.

Host: Andrew Wilner, MD, FACP, FAAN Even with quick thinking and timely action, the chances of a neurosurgeon being able to do more than taking out the bullet, administering antibiotics, and stopping the bleeding isn't likely, and surviving a bullet to the brain can unfortunately be just the beginning of a patient's struggles. Focusing on the title story of his book Bullets and Brains, Dr. Andrew Wilner discusses the serious aftermath congresswoman Gabrielle Giffords experienced while recovering from a headshot.

Host: Matt Birnholz, MD Guest: Wes Ely, MD, MPH After surviving a critical illness, many patients look forward to their lives returning to normal, but unfortunately, that's not always possible. To uncover the far-reaching impacts of delirium, Dr. Matt Birnholz is joined by Dr. Wes Ely, Professor of Medicine and Co-Director of the Center for Critical Illness, Brain Dysfunction and Survivorship Center at Vanderbilt University's School of Medicine which focuses on improving the lives and care of patients in the intensive care unit to ensure both physical and cognitive rehabilitation.

Host: Brian P. McDonough, MD, FAAFP Guest: David Neagle Is it possible that our environment and experiences have subconsciously programmed our emotional response to the world around us? Joining Dr. Brian McDonough is David Neagle, author of The Millions Within: Tips to Improve Emotional Intelligence, to offer advice on what impacts our emotional intelligence and the changes we can implement to strengthen our own. Produced in cooperation with:

Host: Brian P. McDonough, MD, FAAFP In a time when humans walked among wild animals, the fight-or-flight response could've been the difference between eating dinner or being dinner. Today, however, the effect of this stress could be much more problematic for our society. In a review of his findings, Dr. Pratha Dutta joins Dr. Brian McDonough to focus on how our body and immune system react to sympathetic activation and what this might mean for some of your patients.

Host: Maurice Pickard, MD Guest: Allison Pataki Five months pregnant, on a flight headed for Hawaii, Allison Pataki's life took a sudden turn when she witnessed her husband, Dave Levy, lose consciousness. After an emergency landing and evaluation, Levy was found to have had suffered a rare stroke. When he woke the next day, he had amnesia, leaving the young couple holding onto hope for recovery. True to form, Pataki began to write letters to her husband—letters that became the foundation for Beauty in the Broken Places: A Memoir of Love, Faith, and Resilience.

Guest: Stephanie Nahas, MD Assessing patients is an important component to quickly treating the root cause of headache discomfort. Join Dr. Stephanie Nahas, Director of the Headache Medicine Fellowship Program at Thomas Jefferson University, as she provides ‘tools of the trade' to use when presenting patients with treatment options that are right for them. Rethinking Migraine is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for healthcare professionals only.

The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body's infection-fighting immune system. This can cause severe inflammation throughout the body and lead to hospitalization and death, especially if the reaction is not diagnosed and treated quickly. A link to the full communication detailing specific information for health care professionals and a list of FDA-approved GBCAs can be found at www.fda.gov/Drugs/DrugSafety Released 4/25/2018

Host: Brian P. McDonough, MD, FAAFP With a wide spectrum of symptoms, treating depression often becomes frustrating—not only for the patient, but for the primary care physician as well. Joining Dr. Brian McDonough is Dr. Paul Gross, founder of the TMS Center of Lehigh Valley, to address the difficulties of properly identifying depression. Throughout the discussion, Dr. Green also exposes the impactful therapy Transcranial Magnetic Stimulation (TMS), which has been linked to improving other diseases beyond depression.

Host: Maurice Pickard, MD Guest: Carl Hart, MD Carl Hart, who grew up in one of Miami's toughest neighborhoods, escaped a life of crime and drugs and avoided becoming one of the crack addicts he now helps treat as the Chair of the Department of Psychology at Columbia University. His landmark, controversial research is redefining our understanding of addiction and demonstrates how personal experience and scientific study can inform and validate each other for a deeper understanding of human behavior and addiction. Host Dr. Maurice Pickard talks with Dr. Hart, author of the book High Price, about the relationship between drugs and pleasure, choice, and motivation, both in the brain and in society. They explore how his research sheds new light on common ideas about race, poverty, and drugs, and explain why current policies are failing.

Host: Shira Johnson, MD Guest: Bennett Omalu, MD Many studies have demonstrated long-lasting and even permanent brain damage that can originate from just one concussion. With athletes suffering multiple repeated head traumas due to high-contact sports, the controversies over player safety and long-term health risks remain hot-button issues. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for chronic traumatic encephalopathy after autopsying American football players. In this second of a two-part interview, he shares his perspectives on CTE in athletes and the lifelong dangers of contact sports.

Host: Shira Johnson, MD Guest: Bennett Omalu, MD Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others who experience repetitive brain trauma. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for this condition after autopsying American football players. Host Dr. Shira Johnson welcomes Dr. Omalu to share the story of his discovery and the medical, athletic, and public responses that followed.

Host: David Weisman, MD It is estimated that approximately 30% of epilepsy patients are drug-resistant, meaning their seizures do not successfully respond to anti-seizure medications. What other treatment options are available to patients who aren't responding to medication? Host Dr. David Weisman chats with Dr. Lara Marcuse, Co-Director of Mount Sinai Epilepsy Center, about new and emerging treatment options for epilepsy.

Host: Andrew Wilner, MD, FACP, FAAN There is still a great deal to learn about the long term effects of blast injuries on military personnel. Emerging evidence suggests that exposure to a blast can produce both overt and subtle neurological consequences in the brain, but much remains unknown. Host Dr. Andrew Wilner is joined by Dr. Jack Tsao, Director of Traumatic Brain Injury Programs for the US Navy Bureau of Medicine and Surgery, and Professor of Neurology at the University of Tennessee Health Science Center. He is a Captain in the United States Navy, and an expert in detection and prevention of traumatic brain injury in active duty military personnel.

Host: Brian P. McDonough, MD, FAAFP There is nearly a 20% chance that each of us will suffer a concussion this year. More concerning yet, over 30% of those concussions will lead to a long-term, potentially permanent disability. Many studies have explored how the use of Omega-3 fatty acids may add some measure of resilience within the brain to withstand injury in those at significant risk. Host Dr. Brian McDonough chats with Dr. Michael Lewis, founder of the nonprofit Brain Health Education and Research Institute about how the utilization of Omega-3 fatty acids may facilitate the concussion healing process and relieve symptoms.

Host: Brian P. McDonough, MD, FAAFP There is nearly a 20% chance that each of us will suffer a concussion this year. More concerning yet, over 30% of those concussions will lead to a long-term, potentially permanent disability. Many studies have explored how the use of Omega-3 fatty acids may add some measure of resilience within the brain to withstand injury in those at significant risk. Host Dr. Brian McDonough chats with Dr. Michael Lewis, founder of the nonprofit Brain Health Education and Research Institute about how the utilization of Omega-3 fatty acids may facilitate the concussion healing process and relieve symptoms.

Host: Paul Rokuskie Scientists have been doing research into many areas of autism spectrum disorder in the hopes of explaining the doubling of its prevalence rate over the past decade. Both environmental risk factors and genetic components are areas of intense scrutiny for researchers seeking to understand the root causes of autism. Host Paul Rokuskie talks with Craig Newschaffer, Professor, Associate Dean for Research, and Director of the A.J. Drexel Autism Institute, about the risk factors for autism spectrum disorder that scientists are working to better define.

Host: Andrew Wilner, MD, FACP, FAAN While most people with epilepsy are treated with medications, other modalities such as surgery, diet, and neuromodulation are often necessary. Since the FDA approval of the vagus nerve stimulator in 1997, there has been a growing interest in neuromodulation. A second, more sophisticated device, the responsive neurostimulator, received FDA approval in 2013. Host Andrew Wilner talks with Dr. Robert Fisher, Professor of Neurology and Director of the Sandford Epilepsy Center at Stanford University about the role of neuromodulation therapy for treatment of epilepsy.

Host: Brian P. McDonough, MD, FAAFP According to the American Foundation for Suicide Prevention, 44,193 Americans die by suicide each year. The Columbia Suicide Severity Rating Scale (C-SSRS) has been developed as a means of helping users identify whether someone is at risk for suicide, assessing the severity and immediacy of that risk, and gauging the level of support that the person needs. Host Dr. Brian McDonough talks with Dr. Kelly Posner Gerstenhaber, Founder and Director of the Columbia Lighthouse Project who disseminates the C-SSRS worldwide as a tool for suicide prevention.

Host: David Weisman, MD Guest: John Khoury, MD For the first time, the FDA has approved a direct-to-consumer genetic test from 23andme that will inform patients if they are predisposed to diseases such as Parkinson's, Alzheimer's, and Celiac Disease among others. Proponents applaud this decision, saying this will allow for people to know their genetic health risks and be more proactive about their health. Others argue that this information doesn't tell the whole story since predisposition doesn't reflect someone's ultimate risk or likelihood of developing a disease. What are the benefits and liabilities of consumers' access to genetic testing? Host Dr. David Weisman, Director of Clinical Trials at Abington Neurological Associates, sits down with Dr. John Khoury, Associate Director at Abington Memorial Hospital Sleep Disorders Center, to debate the merits and pitfalls of direct-to-consumer genetic testing.

Host: Paul Rokuskie Over the past two decades, the world has seen a dramatic rise of individuals being diagnosed with autism spectrum disorder. For decades scientists and medical professionals have been researching various aspects of this disease to uncover genetic and environmental factors explaining this rapid increase in prevalence; however, discovering definitive clues to causality has proven elusive. Host Paul Rokuskie talks with Dr. Craig Newschaffer, Professor, Associate Dean for Research, and Director of the A.J. Drexel Autism Institute about the latest research findings into environmental factors affecting autism risk.

Host: Paul Rokuskie Researchers have been challenged for years by the simultaneous results of numerous studies into brain network connections in individuals with Autism Spectrum Disorder. Some results show strong connections, while others suggest the opposite. New research has helped bring some clarity to this ongoing paradox. Host Paul Rokuskie is joined by Dr. Benjamin Yerys, a child psychologist in the Center for Autism Research (CAR) at the Children's Hospital of Philadelphia. They talk about how it's possible to see conflicting results and, paradoxically, for both to be true.

Host: Brian P. McDonough, MD, FAAFP Millennials report higher incidence and prevalence rates of depression than any previous generation. Why is this, and what can be done to help these patients? Host Brian McDonough speaks with Dr. John Huber, Chairman for Mainstream Mental Health, about the reasons why millennials are struggling with depression and anxiety, and tips for helping these patients handle the unique stressors in life they are facing.

Host: Paul Rokuskie Autism Spectrum Disorder affects communication skills as well as emotional & social development. Researchers have been studying the brain for decades to better understand how these developmental differences manifest as autism. Recent studies that measure rapid eye movement (REM) have been showing great promise in elucidating the origins and mechanisms of disease. Host Paul Rokusie sits down with Dr. John Foxe to talk about his study on rapid eye movement, its implications on disease pathogenesis, and new insights it can bring to future autism research.

Host: Brian P. McDonough, MD, FAAFP Guest: Allison Willis, MD More men than women are diagnosed with Parkinson's Disease by almost a 2 to 1 margin. However, women receive supportive surgery less often than men, and their symptoms are more severe on average by the time surgical options are taken. Host Brian McDonough chats with Dr. Allison Willis, Assistant Professor of Neurology at the Perelman School of Medicine at the University of Pennsylvania, about gender differences in diagnosing and managing Parkinson's Disease.

Host: Brian P. McDonough, MD, FAAFP Guest: Signe Whitson What is passive-aggressive behavior, and what can (or should) people do when confronted with it? Host Brian McDonough sits down with Signe Whitson, author of the book The Angry Smile: The New Psychological Study of Passive-Aggressive Behavior at Home, at School, in Marriage & Close Relationships, in the Workplace and Online. Ms. Whitson is an educator on bullying, crisis intervention, and child and adolescent emotional and behavioral health. She offers real-world examples and empowering, practical strategies for individuals confronted with passive aggressiveness.

Host: Brian P. McDonough, MD, FAAFP Vegetative state is commonly defined as "wakefulness with awareness." Patients with a vegetative state diagnosis will show only reflex behavior, are not able to follow commands and are unable to communicate. This barrier in the inability for patients to communicate can make it difficult for doctors to measure their level of consciousness. In fact, some patients who are believed to be in a completely vegetative state may be more aware of what's going on than people realize. Host Brian McDonough joins Dr. Adrian Owen, Canada Excellence Research Chair in Cognitive Neuroscience and Imaging at the Brain and Mind Institute at Western University. They talk about how the use of MRI technology is aiding doctors in measuring the level of consciousness in patients under vegetative states.

Host: Andrew Wilner, MD, FACP, FAAN Guest: Elizabeth Donner, MD Sudden Unexplained Death in Epilepsy (SUDEP) refers to the unexplained death of a seemingly healthy person with epilepsy where no cause of death can be found. What do doctors need to know about this mysterious and devastating phenomenon? Dr. Elizabeth Donner, Director of the Comprehensive Epilepsy Program and Associate Professor in the Department of Pediatrics at the University of Toronto joins host Dr. Andrew Wilner to talk about the risks and investigated causes of SUDEP.

Host: Brian P. McDonough, MD, FAAFP Could constant cell phone use be damaging children's brains? Host Dr. Brian McDonough chats with Daniel Debaun, author of Radiation Nation: The Fallout of Modern Technology," about how electromagnetic frequency (EMF) radiation produced by modern technology such as cell phones, tablets, laptops, Wi-Fi, and smart meters may be emerging as a health threat with many unknown consequences.

Host: Adam Ehrlich, MD, MPH Guest: Alison Kaufman, PsyD Our body responds to stress and anxiety in a variety of ways. For patients with IBD, the body manifests stress into various psychological issues, creating a link between IBD and mental health. Dr. Alison Kaufman, a psychologist at Children's Hospital of Philadelphia will discuss the common emotional reactions of IBD patients, suggesting ways for physicians to help these patients cope with their chronic disease. She is joined by Dr. Adam Ehrlich of Temple University.

Host: Maurice Pickard, MD Guest: Annette Hanson, MD Is forced treatment helpful or harmful? Battle lines have been drawn over involuntary treatment for psychiatric patients. Psychiatrist Dr. Annette Hanson offers a thought-provoking and engaging account of the controversy surrounding involuntary psychiatric care in the United States. She brings the issue to life with first-hand accounts from patients, clinicians, advocates, and opponents. Committed takes on the difficult question of psychiatry's role in preventing violence, suicide, and mass murder. Hosted by Dr. Maurice Pickard.

Host: Brian P. McDonough, MD, FAAFP Guest: Annalisa Scimemi Hemorrhagic strokes account for about 200,000 strokes per year. Of those who survive, about 66 percent suffer some permanent brain damage. Our guest, biophysicist Dr. Annalisa Scimemi, has been studying the receptors in the brain that may contribute to brain damage immediately after hemorrhagic stroke. Alongside host Dr. Brian McDonough, she will discuss how to lessen the effects of brain damage following a stroke.

This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Peter Yellowlees, President-elect of the American Telemedicine Association which seeks to improve health care delivery through better use of remote medicine technologies. Dr. Yellowlees discusses his decades of work at the University of California Davis advancing the use of telemedicine in clinical and behavioral care.

This week, hosts Mark Masselli and Margaret Flinter speak with Paul Gionfriddo, CEO of Mental Health America, the nation's oldest organization dedicated to advancing access to mental services for all Americans. He discusses the need to change the nation's response to mental illness from a public safety to a public health approach.

Host: Matt Birnholz, MD Guest: Patrick J. Connolly, MD Back and neck pain is extremely common, with 80-90% of people experiencing some pain within their lifetime. About 90% of cases resolve within six weeks, but for those patients whose pain persists, questions arise as to who should be referred next for further consultation. While patients often see a spine specialist at first, the care journey sometimes leads to a neurosurgeon or orthopaedic spine surgeon. Can this pathway from primary care to neurosurgery or orthopaedic surgery ever be expedited? Dr. Patrick Connolly, neurosurgeon at Penn Medicine joins host Dr. Matt Birnholz to discuss when primary care physicians should consider referring patients to neurosurgeons for neck and back pain. Dr. Connolly will also discuss the different types of surgical options for patients seeking prolonged back and neck pain relief.

Host: Maurice Pickard, MD Dr. Maurice Pickards talks with Dr. Edward Shaw about his book Keeping Love Alive as Memories Fade: The 5 Love Languages and the Alzheimer's Journey. Dr. Shaw shares how love can lift a corner of dementia's dark curtain to cultivate an emotional connection amid memory loss. The book provides focused help for those feeling overwhelmed by the relational toll of Alzheimer's.

Host: David Weisman, MD Dr. David Weisman explores a study from Wake Forest School of Medicine that examined the effects of concussions for youth football participants.

This week hosts Mark Masselli and Margaret Flinter speak with renowned neuroscientist Dr. Adam Gazzaley, Director of the Neuroscience Imaging Center and Gazzaley Lab at UC San Francisco. Dr. Gazzaley discusses his closed loop system designed to improve brain function through personalized game design and feedback, which are already undergoing FDA clinical trials for therapeutic interventions for a number of brain disorders including ADHD, aging brain, PTSD and addiction.

Host: Tim Rush Guest: Fred Moss, MD In today's fast paced world, it can be hard for people to find time in their busy schedules for even the most accessible mainstays of psychological treatment, such as talking to a therapist. Dr. Fred Moss, a Board Certified Psychiatrist and practitioner in the emerging telepsychiatry field, is helping usher in a new response to this problem by utilizing virtual psychiatric services. Is this approach as effective as the in-person visit?